GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » EuBiologics Co Ltd (XKRX:206650) » Definitions » Cyclically Adjusted PB Ratio

EuBiologics Co (XKRX:206650) Cyclically Adjusted PB Ratio : 6.48 (As of Jun. 05, 2025)


View and export this data going back to 2017. Start your Free Trial

What is EuBiologics Co Cyclically Adjusted PB Ratio?

As of today (2025-06-05), EuBiologics Co's current share price is ₩13090.00. EuBiologics Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was ₩2,021.18. EuBiologics Co's Cyclically Adjusted PB Ratio for today is 6.48.

The historical rank and industry rank for EuBiologics Co's Cyclically Adjusted PB Ratio or its related term are showing as below:

XKRX:206650' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 5.41   Med: 6.28   Max: 6.61
Current: 6.45

During the past years, EuBiologics Co's highest Cyclically Adjusted PB Ratio was 6.61. The lowest was 5.41. And the median was 6.28.

XKRX:206650's Cyclically Adjusted PB Ratio is ranked worse than
88.05% of 703 companies
in the Drug Manufacturers industry
Industry Median: 1.97 vs XKRX:206650: 6.45

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

EuBiologics Co's adjusted book value per share data for the three months ended in Mar. 2025 was ₩4,048.716. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₩2,021.18 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


EuBiologics Co Cyclically Adjusted PB Ratio Historical Data

The historical data trend for EuBiologics Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EuBiologics Co Cyclically Adjusted PB Ratio Chart

EuBiologics Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

EuBiologics Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 5.53

Competitive Comparison of EuBiologics Co's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, EuBiologics Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EuBiologics Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, EuBiologics Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where EuBiologics Co's Cyclically Adjusted PB Ratio falls into.


;
;

EuBiologics Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

EuBiologics Co's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=13090.00/2021.18
=6.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EuBiologics Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, EuBiologics Co's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=4048.716/122.5900*122.5900
=4,048.716

Current CPI (Mar. 2025) = 122.5900.

EuBiologics Co Quarterly Data

Book Value per Share CPI Adj_Book
201412 -1,561.820 99.099 -1,932.047
201509 0.000 100.111 0.000
201512 -1,197.052 100.220 -1,464.239
201603 0.000 100.561 0.000
201606 400.521 100.791 487.147
201609 201.929 101.461 243.980
201612 158.317 101.561 191.097
201703 871.340 102.851 1,038.570
201706 808.884 102.611 966.376
201709 764.728 103.491 905.861
201712 725.294 102.991 863.318
201803 810.446 104.101 954.388
201806 1,044.310 104.130 1,229.440
201809 930.452 105.651 1,079.636
201812 976.094 104.351 1,146.704
201903 939.974 104.491 1,102.789
201906 1,095.173 104.881 1,280.093
201909 1,410.681 105.200 1,643.868
201912 1,274.411 105.121 1,486.188
202003 1,524.663 105.354 1,774.096
202006 1,435.472 105.112 1,674.165
202009 294.365 106.198 339.802
202012 2,778.619 105.765 3,220.627
202103 2,711.021 107.357 3,095.685
202106 1,974.247 107.579 2,249.731
202109 3,278.462 108.759 3,695.381
202112 3,308.126 109.676 3,697.634
202203 3,341.063 111.848 3,661.942
202206 3,444.962 114.072 3,702.195
202209 3,502.665 114.715 3,743.108
202212 3,416.373 115.179 3,636.187
202303 3,439.744 116.507 3,619.326
202306 3,467.631 117.182 3,627.661
202309 3,399.000 118.964 3,502.613
202312 3,055.080 118.837 3,151.560
202403 2,970.408 120.123 3,031.407
202406 2,948.342 120.007 3,011.794
202409 3,392.202 120.861 3,440.724
202412 3,613.963 121.135 3,657.366
202503 4,048.716 122.590 4,048.716

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


EuBiologics Co  (XKRX:206650) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


EuBiologics Co Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of EuBiologics Co's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


EuBiologics Co Business Description

Traded in Other Exchanges
N/A
Address
6F Bomnal-A-Chim B/D Mabang-ro 8, Seocho-gu, Seoul, KOR, 06778
EuBiologics Co Ltd is a biopharmaceutical company, which develops and supplies vaccines for epidemics and antibiotic resistance in South Korea. It offers Euvchol, an oral cholera prevention vaccine; and CRM197, a diphtheria toxin mutant vaccine, Inaba Cairo, and among others.

EuBiologics Co Headlines

No Headlines